Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Brands

News Briefs: Help for a friend; Armstrong set for San Remo; New dope easy to detect; O’Grady out for two months

Let's help out a friend.Friends of Kelli Turcotte, UCI Technical Delegate, former employee ofCastelli, GaleForce and the Alt Bike and Board in Minneapolis are gatheringitems for auction and donations to help pay for costly Cancer Treatmenttherapy that Kelli's insurance does not cover.Turcotte, who most recently was the Technical Delegate at the Downhilland Dual World Championships in Vail, has been fighting ovarian cancerwhich has now spread to her liver, lungs and lymph nodes. The type of chemotherapy recommended by her doctor is not covered by her insurance carrier. As she is not

Don't miss a moment from Paris-Roubaix and Unbound Gravel, to the Giro d’Italia, Tour de France, Vuelta a España, and everything in between when you join Outside+.

By VeloNews Interactive

Let’s help out a friend.Friends of Kelli Turcotte, UCI Technical Delegate, former employee ofCastelli, GaleForce and the Alt Bike and Board in Minneapolis are gatheringitems for auction and donations to help pay for costly Cancer Treatmenttherapy that Kelli’s insurance does not cover.Turcotte, who most recently was the Technical Delegate at the Downhilland Dual World Championships in Vail, has been fighting ovarian cancerwhich has now spread to her liver, lungs and lymph nodes. The type of chemotherapy recommended by her doctor is not covered by her insurance carrier. As she is not well enough to work, she has incurred over $17,000 in medical bills.Donations of any kind are being requested for cash, an E-Bay Auctionand a separate raffle to be held during the Sea Otter Race (March 21-24.)The E-Bay Auction will begin on Tuesday March 26th. Please send checks or money orders to Kelli Turcotte; 3631 Lyndale AvenueSouth Minneapolis, MN 55409For donated memorabilia (signed jerseys, a day ride with a pro rider,etc…) or product contributions, send an e-mail description of the items(and a digital photo and retail value if known) by March 13th to MalcolmFearon at blissimages@compuserve.com. You will then be notified whether to ship product to be raffled at the Sea Otter or to ship it to winners of the auction.Feel free to send an e-mail to Kelli at turc0018@tc.umn.eduto wish her well in her recovery from Cancer.Please forward this to everyone who can help support Kelli and/or participate in the auction and raffle.

Armstrong aims for San Remo

Tour de France champion Lance Armstrong will make his seasonal debutat the Milan-San Remo classic on March23, Corriere dello Sport reported Thursday.

Texan Armstrong had been due to compete in this week’s Tour of Murciain Spain but withdrew with a stomach bug and now has switched his attentionto the Milan-San Remo.

French specialist predicts short life for Nesp as performance-enhancerDarbepoetin, or Nesp, the endurance-boosting drug which came to lightduring the Salt Lake Olympics, would have a short lifespan in cycling,according to a top scientist here Thursday.”Nesp is easily detectable,” Professor Jacques de Ceaurriz, directorof the national doping laboratory at Chatenay-Malabry, told the Frenchwire service AFP.No positive results for darbepoetin, contrary to the three positivecases for the drug during the Olympics, have been found in cycling so far.De Ceaurriz believes this is because it is so easy to find, meaningwayward cyclists have been quickly warned off using the drug.”It (darbepoetin) has a very specific profile and is easier to findthan other synthetic EPO (erythropoietin)-type drugs (Eprex, Recormon),”he explained.”We started working with the manufacturer two years ago and last yearwe had worked on a test for it. All that remained for us to do was to checkit.”The Paris-based laboratory is famous for having pioneered the urinetest for EPO – which aids endurance athletes by increasing the amount ofoxygen carried to the red blood cells in the muscles.When darbepoetin made its entry on to the market last year, and wasamong the doping rumours at the Tour of Spain, the laboratory – accreditedby the International Olympic Committee (IOC) – turned its attention towardsrefining a test for it last September.”We were anticipating some (positive tests) when we heard the rumours(of darbepoetin’s use) from the Tour of Spain. But from September to thepresent time we’ve found nothing in the samples we have analysed,” saidProfessor de Ceaurriz.During the Olympics three cross-country skiers tested positive for darbepoetinfollowing analysis of samples at another IOC-accredited laboratory in LosAngeles.After winning his third gold medal of the Games, German Johann Muhlegg,who now skis for Spain, tested positive for darbepoetin and was strippedof his final gold in the men’s 50km classical race.Russian nordic legend Larissa Lazutina was dealt the same blow aftershe had won the women’s 30km gold medal, then tested positive after therace.Her teammate Olga Danilova also tested positive for the same drug.Nesp mimics the effects of EPO, but is said to last longer.(copyright AFP 2002)
 O’Grady faces surgeryCrédit Agricole’s Stuart O’Grady is scheduled to undergo hipsurgery next week and may well be forced to skip the Tour de France teamsources reported Wednesday.It is the second major blow for the French team, whose leader ChristopheMoreau has been out with injury since the beginning of the season.A Toulouse specialist who examined O’Grady recently determined thatthe recurring pain the sprinter has been experiencing in his leg will requirean operation to repair the iliac artery in his hip.O’Grady  will require at least one month’s complete rest and thenanother month without competition to recover properly. That means the Aussiewill not be back before May, leaving him little time to prepare for theTour, which starts in Luxembourg on July 6.(copyright AFP 2002)